Status:

COMPLETED

Objective Testing of Tear Film Stability

Lead Sponsor:

Manhattan Vision Associates

Collaborating Sponsors:

Alcon Research

Conditions:

Contact Lens Solutions

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate the in-vivo wettability of soft contact lenses when cared with two different multi-purpose solutions over a two week wearing period.

Eligibility Criteria

Inclusion

  • The subject must be at least 18 years of age and no more than 80 years of age.
  • The subject must have a best corrected visual acuity of 20/30 or better for each eye.
  • The subject must habitually wear contact lenses.
  • The subject must have had an eye exam within the last 12 months. The exam data must be available to the investigators prior to the first visit.
  • The subject must have normal eyes, no use of ocular medications, no ocular infection of any type, and no ocular inflammation.
  • The subject must read understand and sign the Statement of Informed Consent.
  • The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.

Exclusion

  • Ocular or systemic allergies or disease that might interfere with contact lens wear.
  • Systemic disease, autoimmune disease or use of medication which might interfere with contact lens wear.
  • Clinically significant (FDA Scale grade 3 or 4) corneal edema, corneal vascularization, corneal staining or any other abnormalities of the cornea which would contraindicate contact lens wear.
  • Clinically significant (FDA Scale grade 3 or 4) tarsal abnormalities or bulbar injection which might interfere with contact lens wear.
  • Any ocular infection.
  • Pregnancy or lactation.
  • Diabetes
  • Infectious diseases (e.g. hepatitis, tuberculosis)
  • Contagious immunosuppressive diseases (e.g. HIV)

Key Trial Info

Start Date :

September 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2008

Estimated Enrollment :

32 Patients enrolled

Trial Details

Trial ID

NCT00789529

Start Date

September 1 2008

End Date

November 1 2008

Last Update

May 31 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

MVA/IVR

New York, New York, United States, 10022